- Syndax Pharmaceuticals granted inducement stock options covering up to 228,500 common shares to eight new employees under its 2023 Inducement Plan.
- Awards were granted on April 1, 2026.
- Options vest over four years, with 25% vesting on one-year anniversary of vesting start date.
- Remaining options vest in equal monthly installments of 1/48 over the next 36 months, subject to continued service.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syndax Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604031601PRIMZONEFULLFEED9682997) on April 03, 2026, and is solely responsible for the information contained therein.
Comments